MEKTOVI
Identification of Mektovi
| No description |
Google image searchProduct monograph
Active ingredient
binimetinib, 15 MG
DIN: 02513080
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: PFIZER CANADA ULC
Date: 05-JUL-2021
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
- L01EE — Mitogen-activated protein kinase (MEK) inhibitors (ATC, ATC/DDD)
- L01EE03 — BINIMETINIB (ATC/DDD)
Reference brand drug: Mektovi
